PPD strengthens its presence in Eastern Europe

Published: 24-Jun-2008

US-based global contract research organisation PPD is to open an office in Istanbul, Turkey, continuing the company's growth of its Phase II-IV clinical development services in Eastern Europe. PPD will provide clinical monitoring services in key therapeutic areas from this location.


US-based global contract research organisation PPD is to open an office in Istanbul, Turkey, continuing the company's growth of its Phase II-IV clinical development services in Eastern Europe. PPD will provide clinical monitoring services in key therapeutic areas from this location.

The new office strengthens PPD's presence in Eastern Europe beyond Russia and Ukraine, countries where the company is expanding through its pending acquisition of InnoPharm. Eastern Europe is an important, high-growth market for clinical trials and a region PPD has targeted for expansion.

"With a population of 74 million people, Turkey is becoming an attractive place to conduct clinical trials," said Fred Eshelman, ceo of PPD. "Eastern Europe offers recruitment opportunities and quality investigators, and our Istanbul office is an important part of our strategic growth in this region."

You may also like